Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Anyone read the filing? Looks to me like S AND L Both own 9.99%

beneficially own 9.99%. Swartz and Lincoln are treated as related firms so this is why they are treated as beneficial owners. They beneficially own 9.99%. in essence meaning between the two of them. They own 38M shares plus 30M+/- warrants combined.

As for this company currently being run as a shell, all evidence points to it until management can proven to me otherwise. I'm hoping that they will prove me wrong and that's why I'm still here.

dot 

Share
New Message
Please login to post a reply